Stay updated with breaking news from Nasdaq Allo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Rating)’s stock price reached a new 52-week low during mid-day trading on Tuesday after HC Wainwright lowered their price target on the stock from $29.00 to $23.00. The company traded as low as $4.81 and last traded at $4.82, with a volume of 412054 shares changing hands. The stock […]
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Rating) shares hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $4.91 and last traded at $4.92, with a volume of 840064 shares traded. The stock had previously closed at $5.03. Wall Street Analyst Weigh In A number of equities research […]
Sanford C. Bernstein assumed coverage on shares of Allogene Therapeutics (NASDAQ:ALLO – Get Rating) in a research note issued to investors on Tuesday morning, The Fly reports. The brokerage issued a market perform rating and a $6.00 target price on the stock. Several other brokerages also recently commented on ALLO. Truist Financial cut their target […]
Allogene Therapeutics (NASDAQ:ALLO – Get Rating)‘s stock had its “outperform” rating restated by research analysts at William Blair in a report released on Wednesday, PriceTargets.com reports. Other equities research analysts have also issued reports about the company. JPMorgan Chase & Co. upgraded Allogene Therapeutics from a “neutral” rating to an “overweight” rating and reduced their […]
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Rating) – Investment analysts at Zacks Research issued their FY2025 earnings per share (EPS) estimates for Allogene Therapeutics in a report released on Tuesday, March 14th. Zacks Research analyst S. Ganoria anticipates that the company will earn ($2.61) per share for the year. The consensus estimate for Allogene Therapeutics’ […]